Filing Details
- Accession Number:
- 0001628280-24-049897
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-04 15:35:53
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-04 15:35:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1706431 | Vir Biotechnology Inc. | VIR | Biological Products, (No Disgnostic Substances) (2836) | 812730369 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2036234 | Vanina Verneuil De | C/O Vir Biotechnology, Inc. 1800 Owens Street, Suite 900 San Francisco CA 94158 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-02 | 76 | $8.22 | 56,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold pursuant to a sale instruction entered into on May 28, 2024, whereby shares purchased on November 29, 2024 pursuant to the Issuer's employee stock purchase program were automatically sold six months after the instruction date.
- Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024.
Billionaire Hedge Funds
